| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/15/2004 | US20040072162 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 04/15/2004 | US20040072146 Using peptide modulator to prevent associations between adenine nucleotide translocator (ANT) and viral replication proteins (VPR); antiapoptosis |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071723 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071722 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071714 A gene expressed polypeptide is used in food, for treating food allergy |
| 04/15/2004 | US20040071688 Reduced or removed potential T cell epitopes |
| 04/15/2004 | CA2505132A1 Method for screening modulators of mitochondrial fuctionning and new modulators obtained |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | CA2500897A1 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 04/15/2004 | CA2500833A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | CA2500830A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | CA2500827A1 Tumor targeting agents and uses thereof |
| 04/14/2004 | EP1408048A1 Vaccines of enhanced immunogenicity, and methods for preparing such vaccines |
| 04/14/2004 | EP1406921A1 Hypoglycaemic peptides and methods of use thereof |
| 04/14/2004 | CN1145695C Antifungal protein |
| 04/13/2004 | US6720311 To cause apoptosis in colon cancer and prostate cancer cells |
| 04/13/2004 | US6719974 Heat shock protein-based vaccines and immunotherapies |
| 04/13/2004 | US6719972 Induce antigen specific apoptosis in activated t cells; ligands with monoclonal anti-ctla4 antibody that binds to an epitope of ctla4 |
| 04/13/2004 | CA2322963C Methods to increase white blood cell survival after chemotherapy |
| 04/08/2004 | WO2004029273A1 Production method of iturin a and its homologues |
| 04/08/2004 | WO2004029080A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 04/08/2004 | WO2004029073A2 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | WO2004007702A3 Modulators of chloride intracellular channel 1 protein signaling ____________________________________________________________ |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003100015A3 Polypeptide cleavage process |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003084979A3 Novel peptides and the application thereof in therapy |
| 04/08/2004 | WO2003076455A3 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 04/08/2004 | WO2003042249A8 Peptide purification by means of metal ion affinity chromatography |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2002076173A3 Inhibitors of glycosaminoglycans |
| 04/08/2004 | US20040068094 Ring modified cyclic peptide analogs |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067879 Effective against fungi such as Candida parapsilosis, Candida albicans, Cryptococcus neoformans, and/or Histoplasma capsulatum |
| 04/08/2004 | US20040067878 Novel lipopeptides as antibacterial agents |
| 04/08/2004 | CA2498826A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | CA2497767A1 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 04/07/2004 | EP1405911A1 Interaction trap systems for detecting protein interactions |
| 04/07/2004 | EP1405858A1 Process for producing sugar chain asparagine derivative |
| 04/07/2004 | EP1404877A2 New assays for preimplantation factor and preimplantation factor peptides |
| 04/07/2004 | EP1404806A1 Male contraceptives |
| 04/07/2004 | EP1404704A1 Bridged bicyclic serine protease inhibitors |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404362A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 04/07/2004 | EP1404358A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2004 | EP1404357A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 04/07/2004 | EP0888543A4 Azatide peptidomimetics |
| 04/07/2004 | CN1487952A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 04/07/2004 | CN1144584C Sustained-release compositions and method for preparing the same |
| 04/06/2004 | US6716963 Peptide antiangiogenic drugs |
| 04/06/2004 | US6716962 Contacting the antibiotic with a divalent metal ion and an organic solvent, to extract the lipopeptide antibiotic into the solvent; and contacting the extract of the lipopeptide antibiotic with acid. |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716811 Low white blood cell titer |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716583 Methods of producing nucleic acid ligands |
| 04/06/2004 | CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/01/2004 | WO2004026898A1 Peptide complexes containing phospholipase d |
| 04/01/2004 | WO2004026896A2 Hcv ns-3 serine protease inhibitors |
| 04/01/2004 | WO2004026894A2 Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity |
| 04/01/2004 | WO2004026329A1 Peptides and related molecules that modulate nerve growth factor activity |
| 04/01/2004 | WO2004026328A1 Compstatin analogs with improved activity |
| 04/01/2004 | WO2004026327A1 Homing peptides to receptors of heart vasculature |
| 04/01/2004 | WO2004003008A3 Peptides for inducing apoptosis in tumor cells |
| 04/01/2004 | WO2003099868B1 Method for obtaining anti-idiotype antibodies |
| 04/01/2004 | WO2003099780A3 Luminogenic protease substrates |
| 04/01/2004 | WO2003096022A3 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 04/01/2004 | WO2003087138A3 Methods for identifying polypeptide factors interacting with rna |
| 04/01/2004 | WO2003054146A3 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 04/01/2004 | WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/01/2004 | US20040063917 Modified erythropoietin (epo) with reduced immunogenicity |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063634 Modified kertinocyte growth factor (kgf) with reduced immunogenicity |
| 04/01/2004 | US20040063631 Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu amino acid sequence |
| 04/01/2004 | US20040063625 Cyclic peptide |
| 04/01/2004 | US20040063623 Formulation of boronic acid compounds |
| 04/01/2004 | US20040063621 Heterocarpine, a human ghrh-binding protein |
| 04/01/2004 | US20040062749 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 04/01/2004 | CA2833202A1 Compstatin analogs with improved activity |
| 04/01/2004 | CA2767235A1 Peptides and related molecules that modulate nerve growth factor activity |
| 04/01/2004 | CA2538719A1 Gd2 ligands |
| 04/01/2004 | CA2502690A1 Compstatin analogs with improved activity |
| 03/31/2004 | EP1403284A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION |
| 03/31/2004 | EP1402001A2 Anti-microbial peptides and compositions |
| 03/31/2004 | EP1401864A1 Methods and compositions for modulating ace-2 activity |
| 03/31/2004 | EP1401863A1 Somatostatin-dopamine chimeric analogs |
| 03/31/2004 | EP1401862A2 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401478A2 Antimicrobial peptides |
| 03/31/2004 | EP1401476A2 Igf antagonist peptides |
| 03/31/2004 | EP1401473A2 Transporters comprising spaced arginine moieties |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401467A1 Alpha-fetoprotein peptides and uses thereof |